Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

被引：82
|
作者：
Sharun, Khan [1 ]
Dhama, Kuldeep [2 ]
Patel, Shailesh Kumar [2 ]
Pathak, Mamta [2 ]
Tiwari, Ruchi [3 ]
Singh, Bhoj Raj [4 ]
Sah, Ranjit [5 ]
Bonilla-Aldana, D. Katterine [6 ,7 ]
Rodriguez-Morales, Alfonso J. [7 ,8 ]
Leblebicioglu, Hakan [9 ]
机构：
[1] ICAR Indian Vet Res Inst, Div Surg, Bareilly 243122, Uttar Pradesh, India
[2] ICAR Indian Vet Res Inst, Div Pathol, Bareilly 243122, Uttar Pradesh, India
[3] UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vig, Dept Vet Microbiol & Immunol, Coll Vet Sci, Mathura 281001, India
[4] ICAR Indian Vet Res Inst, Div Epidemiol, Bareilly 243122, Uttar Pradesh, India
[5] Tribhuvan Univ Teaching Hosp, Inst Med, Dept Microbiol, Kathmandu, Nepal
[6] Fdn Univ Autonoma Amer, Semillero Zoonosis, Grp Invest BIOECOS, Sede Pereira, Pereira, Risaralda, Colombia
[7] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Colombia
[8] Fdn Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira, Risaralda, Colombia
[9] Samsun Liv Hosp, Dept Infect Dis, Samsun, Turkey
来源：
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS | 2020年 / 19卷 / 01期
关键词：
COVID-19; 2019-nCoV; SARS-CoV-2; Coronavirus; Therapeutics; Ivermectin; NUCLEAR IMPORT; WONDER DRUG; VIRUS; REPLICATION; INHIBITORS;
D O I：
10.1186/s12941-020-00368-w
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
    Khan Sharun
    Kuldeep Dhama
    Shailesh Kumar Patel
    Mamta Pathak
    Ruchi Tiwari
    Bhoj Raj Singh
    Ranjit Sah
    D. Katterine Bonilla-Aldana
    Alfonso J. Rodriguez-Morales
    Hakan Leblebicioglu
    [J]. Annals of Clinical Microbiology and Antimicrobials, 19
  • [2] Candidate drugs against SARS-CoV-2 and COVID-19
    McKee, Dwight L.
    Sternberg, Ariane
    Stange, Ulrike
    Laufer, Stefan
    Naujokat, Cord
    [J]. PHARMACOLOGICAL RESEARCH, 2020, 157
  • [3] New therapeutic approaches for SARS-CoV-2/COVID-19
    Rodriguez-Morales, Alfonso J.
    Barbosa, Alexandre Naime
    Cimerman, Sergio
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [4] Ebselen, a new candidate therapeutic against SARS-CoV-2
    Haritha, C. V.
    Sharun, Khan
    Jose, Bosco
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2020, 84 : 53 - 56
  • [5] Naringenin as a Possible Candidate Against SARS-CoV-2 Infection and in the Pathogenesis of COVID-19
    Agrawal, Pawan K.
    Agrawal, Chandan
    Blunden, Gerald
    [J]. NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (12)
  • [6] Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review
    Jeong, Gi Uk
    Song, Hanra
    Yoon, Gun Young
    Kim, Doyoun
    Kwon, Young-Chan
    [J]. FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [7] Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19
    Sharma, Homa Nath
    Latimore, Charity O. D.
    Matthews, Qiana L.
    [J]. PATHOGENS, 2021, 10 (09):
  • [8] Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
    Low, Zheng Yao
    Yip, Ashley Jia Wen
    Lal, Sunil K.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2022, 1868 (02):
  • [9] Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
    Sadat, Seyed Mehdi
    Aghadadeghi, Mohammad Reza
    Yousefi, Masoume
    Khodaei, Arezoo
    Sadat Larijani, Mona
    Bahramali, Golnaz
    [J]. MOLECULAR BIOTECHNOLOGY, 2021, 63 (05) : 389 - 409
  • [10] Letter to the Editor in response to the article 'Candidate drugs against SARS-CoV-2 and COVID-19'
    Campesi, Ilaria
    Montella, Andrea
    Franconi, Flavia
    [J]. PHARMACOLOGICAL RESEARCH, 2021, 163
12345